Mission Street and BGO have secured a resolution to grant planning permission from Oxford City Council for Phase 2 of their development in the West End of Oxford. Known as Fabrica, the scheme will provide 180,000 sq ft of innovation real estate within a 10-minute walk from Oxford station and city centre. Designed by NBBJ, […]
Contractor 8build has secured the job to deliver the second phase of a 100,000 sq ft life sciences development in Cambridge. The Press biotech scheme is being developed by specialist investors Mission Street and BGO and will see lab and office space built either as a headquarters building or up to six smaller suites. This […]
Growing company has identified lack of space in sector hotspots According to the latest figures from DTRE, there’s nearly 900,000 sq ft of latent demand for life sciences space in Cambridge alone – and investment volumes have hit £139m in 2023 to date, with a further £88m under offer. Not bad for just one part of […]
Artem Korolev spoke about the numerous infrastructure challenges faced by UK science and innovation businesses as they scale. Collaboration between a wide variety of public and private stakeholders will be critical to unlock this sustainably. https://www.reuters.com/world/uk/lab-crunch-british-science-has-nowhere-go-2023-06-20/
Mission Street have received planning consent for 64,500 sq ft of life science space in the Cambridge Southern Cluster. Construction of the scheme is due to commence this summer, with completion slated for mid-2024. This will follow phase one, which is under construction and will provide two fitted lab and office suites totalling 16,000 sq […]
The scheme is part of Mission Street’s joint venture with BentallGreenOak (BGO) Due for completion in Q4 2023, Inventa is delivering much-needed lab space in Oxford Announcement comes as the government doubles down on its ‘science superpower’ ambitions Mission Street, a specialist investor, developer and operator for the science and innovation sector, last week ‘topped […]
